Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ · Healthcare
Madrigal Pharmaceuticals, Inc. Total Liabilities 2012–2025
Madrigal Pharmaceuticals, Inc. annual total liabilities history from 2012 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Madrigal Pharmaceuticals, Inc. total liabilities as of December 31, 2025: 656.9M, a 128.20% increase year-over-year.
- Madrigal Pharmaceuticals, Inc. total liabilities for 2025 were 656.9M, a 128.20% increase from 2024.
- Madrigal Pharmaceuticals, Inc. total liabilities for 2024 were 287.9M, a 22.38% increase from 2023.
- Madrigal Pharmaceuticals, Inc. total liabilities for 2023 were 235.2M, a 42.40% increase from 2022.
- Madrigal Pharmaceuticals, Inc. total liabilities for 2022 were 165.2M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Madrigal Pharmaceuticals, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $657 |
| 2024 | $288 |
| 2023 | $235 |
| 2022 | $165 |
| 2021 | $77 |
| 2020 | $47 |
| 2019 | $25 |
| 2018 | $8 |
| 2017 | $10 |
| 2012 | $28 |
Madrigal Pharmaceuticals, Inc. Total Liabilities — FAQ
Madrigal Pharmaceuticals, Inc. (MDGL) total liabilities over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MDGL's total liabilities history?
The chart and table above show Madrigal Pharmaceuticals, Inc.'s total liabilities by year and by quarter, including the growth rate.